Focus on bladder cancer - PubMed (original) (raw)
Review
doi: 10.1016/j.ccr.2004.08.002.
David J McConkey, Randall E Millikan, Xifeng Wu, Menashe Bar-Eli, Liana Adam, Ashish M Kamat, Arlene O Siefker-Radtke, Tomasz Tuziak, Anita L Sabichi, H Barton Grossman, William F Benedict, Bogdan Czerniak
Affiliations
- PMID: 15324694
- DOI: 10.1016/j.ccr.2004.08.002
Free article
Review
Focus on bladder cancer
Colin P N Dinney et al. Cancer Cell. 2004 Aug.
Free article
No abstract available
Similar articles
- Analysis of genetic alterations in normal bladder urothelium.
Leonardo C, Gallucci M, Cianciulli AM. Leonardo C, et al. Urology. 2004 Aug;64(2):405; author reply 405-6. doi: 10.1016/j.urology.2004.01.054. Urology. 2004. PMID: 15302516 No abstract available. - Tight junctions and bladder cancer (review).
Haynes MD, Martin TA, Jenkins SA, Kynaston HG, Matthews PN, Jiang WG. Haynes MD, et al. Int J Mol Med. 2005 Jul;16(1):3-9. Int J Mol Med. 2005. PMID: 15942671 Review. - [Detection of oncoprotein E7 HPV16 in the cancer and normal urinary bladder urothelium].
Volgareva GM, Zavalishina LE, Golovina DA, Andreeva IuIu, Ermilova VD, Cheban NL, Kuevda DA, Trofimova OB, Shipulina OIu, Pavlova LS, Petrov AN, Matveev VB, Shtil' AA, Frank GA. Volgareva GM, et al. Arkh Patol. 2009 Jan-Feb;71(1):29-30. Arkh Patol. 2009. PMID: 19514355 Russian. - Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage.
Caprodossi S, Lucciarini R, Amantini C, Nabissi M, Canesin G, Ballarini P, Di Spilimbergo A, Cardarelli MA, Servi L, Mammana G, Santoni G. Caprodossi S, et al. Eur Urol. 2008 Sep;54(3):612-20. doi: 10.1016/j.eururo.2007.10.016. Epub 2007 Oct 16. Eur Urol. 2008. PMID: 17977643 - Utility of diagnostic and prognostic markers in urothelial carcinoma of the bladder.
Coleman JF, Hansel DE. Coleman JF, et al. Adv Anat Pathol. 2009 Mar;16(2):67-78. doi: 10.1097/PAP.0b013e318199f89e. Adv Anat Pathol. 2009. PMID: 19550368 Review.
Cited by
- The Evolution of Nadofaragene Firadenovec: A Review and the Path Forward.
Steinmetz AR, Mokkapati S, McConkey D, Dinney CP. Steinmetz AR, et al. Bladder Cancer. 2024 Jun 18;10(2):105-112. doi: 10.3233/BLC-230083. eCollection 2024. Bladder Cancer. 2024. PMID: 39131870 Free PMC article. Review. - Upper Tract Urothelial Carcinoma (UTUC): Prevalence, Impact and Management Challenge.
Nally E, Young M, Chauhan V, Wells C, Szabados B, Powles T, Jackson-Spence F. Nally E, et al. Cancer Manag Res. 2024 May 17;16:467-475. doi: 10.2147/CMAR.S445529. eCollection 2024. Cancer Manag Res. 2024. PMID: 38774494 Free PMC article. Review. - Loss of LPAR6 and CAB39L dysregulates the basal-to-luminal urothelial differentiation program, contributing to bladder carcinogenesis.
Lee S, Bondaruk J, Wang Y, Chen H, Lee JG, Majewski T, Mullen RD, Cogdell D, Chen J, Wang Z, Yao H, Kus P, Jeong J, Lee I, Choi W, Navai N, Guo C, Dinney C, Baggerly K, Mendelsohn C, McConkey D, Behringer RR, Kimmel M, Wei P, Czerniak B. Lee S, et al. Cell Rep. 2024 May 28;43(5):114146. doi: 10.1016/j.celrep.2024.114146. Epub 2024 Apr 25. Cell Rep. 2024. PMID: 38676926 Free PMC article. - Identification of novel protein biomarkers from the blood and urine for the early diagnosis of bladder cancer via proximity extension analysis.
Kong T, Qu Y, Zhao T, Niu Z, Lv X, Wang Y, Ding Q, Wei P, Fu J, Wang L, Gao J, Zhou C, Wang S, Jiang J, Zheng J, Wang K, Wu K. Kong T, et al. J Transl Med. 2024 Mar 26;22(1):314. doi: 10.1186/s12967-024-04951-z. J Transl Med. 2024. PMID: 38532419 Free PMC article. - Targeting histone modifiers in bladder cancer therapy - preclinical and clinical evidence.
Zhang S, Lin T, Xiong X, Chen C, Tan P, Wei Q. Zhang S, et al. Nat Rev Urol. 2024 Aug;21(8):495-511. doi: 10.1038/s41585-024-00857-z. Epub 2024 Feb 19. Nat Rev Urol. 2024. PMID: 38374198 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical